SCHEMBL2288977

SCHEMBL2288977

C=CCOc1cc(OC)c(C(=O)/C=C/c2ccc(OC)cc2OC)c(OCC=C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.58
MAPT P10636 6/20 0.57
TNFRSF1A P19438 1/20 0.57
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
ALDH1A1 P00352 3/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
PTPN1 P18031 3/20 0.54
MAPK1 P28482 2/20 0.54
HPGD P15428 2/20 0.53
LMNA P02545 1/20 0.53
PKM P14618 1/20 0.53
LY96 Q9Y6Y9 1/20 0.52
CHRNA7 P36544 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.51
TP53 P04637 2/20 0.51
CYP1A1 P04798 2/20 0.51
KDM4E B2RXH2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2288989 1.00 FLT3 (0.58) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL2284249 0.87 FLT3 (0.73) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL2284259 0.87 FLT3 (0.73) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL7184798 0.86 TNFRSF1A (0.74) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL7177833 0.86 TNFRSF1A (0.74) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL12375190 0.85 ABCG2 (0.70) FLT3MAPTTNFRSF1AMEN1KMT2A
SCHEMBL2283527 0.84 ABCG2 (0.64) FLT3MAPTMEN1KMT2AHPGD
SCHEMBL2283523 0.84 ABCG2 (0.64) FLT3MAPTMEN1KMT2AHPGD
SCHEMBL4450671 0.84 MAPT (0.74) MAPTTNFRSF1AMEN1KMT2AALDH1A1
SCHEMBL4450678 0.84 MAPT (0.74) MAPTTNFRSF1AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
WO-2010019861-A1 COMPOUNDS, THEIR SYNTHESES, AND THEIR USES UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES TERT, TYMS, NISCH FLT3 213/4885MAPT 2194/4885TNFRSF1A 3980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.